Foghorn Therapeutics Inc. (FHTX)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $368k
- Sep 23 · Routine
- Form 4 sales
- 6
- On record
- Form 144 notices
- 1
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 144 noticeNoticeAug 16 2023
Filed to sell 311,297 shares ($2.6M)
Agresta Samuel, Officer
No 10b5-1 planFirst sale on recordFiling
- 2 Form 4 saleUnusualAug 16 same day
Sold 311,297 shares at $8.25 ($2.6M)
Agresta Samuel, Chief Medical Officer
No 10b5-1 planSold 100% of holdings ($2.6M position)0 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 4 saleNo planMar 11 +208 days
Sold 11,000 shares at $6.56 ($72k)
Cavalie Fanny, Chief Strategy/Bus Ops Officer
No 10b5-1 planSold 12.6% of holdings ($571k position)75,992 shares leftFirst sale on recordFiling
- 4 Form 4 saleRoutineSep 9 +182 days
Sold 20,000 shares at $9.50 ($190k)
Bellon Steven F., Chief Scientific Officer
10b5-1 planSold 16.4% of holdings ($1.2M position)101,957 shares leftFirst sale on recordFiling
- 5 Form 4 saleRoutineSep 17 +8 days
Sold 10,672 shares at $10.04 ($107k)
Costa Carlos, Chief People Officer
10b5-1 planSold 100% of holdings ($107k position)0 shares leftFirst sale on recordFiling
- 6 Form 4 saleRoutineSep 18 +1 day
Sold 11,574 shares at $10.05 ($116k)
Costa Carlos, Chief People Officer
10b5-1 planSold 100% of holdings ($116k position)0 shares leftFiling
- 7 Form 4 saleRoutineSep 23 +5 days
Sold 36,613 shares at $10.04 ($368k)
Costa Carlos, Chief People Officer
10b5-1 planSold 100% of holdings ($368k position)0 shares leftFiling
Every transaction
Loading transactions…
Sales, notices and lockups (7)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2024 | Costa Carlos | Chief People Officer | Form 4 sale | 36,613 | $368k | 100.0% | Routine | SEC |
| Sep 18, 2024 | Costa Carlos | Chief People Officer | Form 4 sale | 11,574 | $116k | 100.0% | Routine | SEC |
| Sep 17, 2024 | Costa Carlos | Chief People Officer | Form 4 sale | 10,672 | $107k | 100.0% | Routine | SEC |
| Sep 9, 2024 | Bellon Steven F. | Chief Scientific Officer | Form 4 sale | 20,000 | $190k | 16.4% | Routine | SEC |
| Mar 11, 2024 | Cavalie Fanny | Chief Strategy/Bus Ops Officer | Form 4 sale | 11,000 | $72k | 12.6% | No plan | SEC |
| Aug 16, 2023 | Agresta Samuel | Chief Medical Officer | Form 4 sale | 311,297 | $2.6M | 100.0% | Unusual | SEC |
| Aug 16, 2023 | Agresta Samuel | Officer | Form 144 notice | 311,297 | $2.6M | Notice | SEC |